What is the mechanism of action for Vabysmo? Official answer: Vabysmo (faricimab) works by blocking two pathways that cause abnormal blood vessel growth in the eye. It attaches to...

#Vabysmo (faricimab) blocks two proteins—VEGF and Ang-2—that cause abnormal blood vessel growth in the eye. This reduces vessel leakage and macular swelling, protecting central vision affected by retinal conditions.

Boehringer raises hope of oral drug for diabetic eye disease Boehringer has started a phase 2 trial of an oral therapy that could help people with diabetic macular oedema avoid regular injections into the eye.

#Ophthalmology #BoehringerIngelheim #diabeticeyedisease #diabeticmacularoedema #DME #BI1815368 #THULITEstudy #centreinvolvedDME #VEGFtargetingdrugs #Roche #Vabysmo #faricimab #Lucentis #ranibizumab #Bayer #Regeneron #Eylea #aflibercept #Susvimo #ranibizumab
pharmaphorum.com/news/boehrin...

How does Vabysmo work? Official answer: Vabysmo (faricimab) works by blocking two pathways that cause abnormal blood vessel growth in the eye. It attaches to...

#Vabysmo targets two key pathways that cause abnormal blood vessel growth in the eye. It blocks:
🔹 VEGF: Involved in blood vessel growth and leakage.
🔹 Ang-2: Promotes abnormal blood vessel growth.
By stopping these proteins, Vabysmo improves vision and eye health.